Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Kamux Oyj: Kamux Corporation's Half Year Financial Report for January-June 2018

Kamux Corporation         Half Year Financial Report                  August 23, 2018 09:00 Kamux Corporation's Half Year Financial Report for January-June 2018 KAMUX'S ADJUSTED OPERATING PROFIT INCREASED BY 36.2% IN APRIL-JUNE 2018 The figures in parenthesis refer to the comparison period, i.e. the same period in the previous year, unless otherwise mentioned. April-June in brief - The number of cars sold increased by 15.7% to 11,433 cars (9,882) - Revenue increased by 17.2%, totaling EUR 128.0 million (109.2) - Gross profit increased by 25.7% to EUR 16.3 million (13.0),

TECHSTEP WINS CONTRACT WITH DIFI – THE NORWEGIAN GOVERNMENT’S AGENCY FOR PUBLIC MANAGEMENT AND EGOVERNMENT

Techstep has won a framework agreement with Difi, the Norwegian government’s Agency for public management and eGovernment. Under the agreement, Techstep will provide mobile solutions comprising mobile phones and tablets, related equipment, and operating and support services to Difis organisations and their employees. The agreement will be entered into with Difi’s Department of Public Procurement and will be signed shortly after the closing date for submission of complaints, which is due 3 September 2018. The potential contract value is NOK 200 million excluding options, with the majority

Strong start to 2018 for Zound Industries

Following on from a record close to 2017, Zound Industries has seen continued strong sales during the first six months of 2018. Net sales grew by 27 percent to 740 M SEK, compared to 585 M SEK for the same period last year.“To continue the success of 2017 is phenomenal. Our focus on building a solid foundation for future growth is paying off and we’re now looking forward to see what the second half of the year brings. We have great confidence in the company and in the team,” says Tommy Jacobson, Chairman of the Board at Zound Industries. This year has seen several new product launches

Sari Näkki appointed Vice President, HR and a member of the management group at Detection Technology

Detection Technology Plc company announcement 23 August 2018 at 9:00 (EEST) Sari Näkki appointed Vice President, HR and a member of the management group at Detection Technology Sari Näkki (born in 1971, M.Sc. in Economics) has been appointed Vice President, Human Resources and a member of the management group at the Detection Technology group. She will be responsible for the group's human resources management globally. Sari Näkki will join the company on 26 September 2018, and will report to President and CEO Hannu Martola. Han Ming, the current HR Director of the group, has

Interim report January 1- June 30, 2018

RaySearch Laboratories AB (publ) “In the second quarter of 2018, order intake excluding service agreements rose 47 percent to SEK 160 M, which is the highest order intake ever for the second quarter. Net sales declined marginally to SEK 141 M (142) and the operating margin remained unchanged at 19 percent (19), mainly due to the change in accounting policies, but also to positive currency effects. Without application of the new accounting policies, net sales would have risen 15 percent to SEK 162 M and the operating margin would have been 28 percent. Our order backlog including service

Correction: Multiconsult ASA second quarter and first half 2018

Reason for correction: Attachments replacedMulticonsult delivered net operating revenue growth of 20.1 per cent in the quarter, 13.5 per cent year to date. EBIT in the second quarter was NOK 48.9 million and NOK 85.0 million in the first half 2018. Oslo, 23 August 2018 - Multiconsult delivered a second quarter revenue growth of 20.1 per cent to NOK 887.6 million (NOK 738.9 million) compared to the same quarter last year. The increase in net operating revenues reflects higher production due to acquisition of the Hjellnes group. A calendar effect of five more working days in Norway, of

Höegh LNG : Key information relating to the cash dividend to be paid by Höegh LNG Holdings Ltd.

Hamilton, Bermuda, 23 August 2018 - Key information relating to the cash dividend to be paid by Höegh LNG Holdings Ltd. Amount: USD 0.025 per shareDeclared currency: United States DollarLast day including right: 5 September 2018Ex-date: 6 September 2018Record date: 7 September 2018Payment date: On or about 21 September 2018Date of approval: 22 August 2018 * * * About Höegh LNG: Höegh LNG operates world-wide with a leading position as owner and operator of floating LNG import terminals; floating storage and regasification units (FSRUs), and is one of the most

Höegh LNG : Interim results for the quarter and half year ended 30 June 2018

Hamilton, Bermuda, 23 August 2018 - Höegh LNG Holdings Ltd. ("Höegh LNG") today reports its financial results for the quarter and half year ended 30 June 2018 Highlights for the second quarter of 2018: · EBITDA of USD 40.3 million · Profit after tax of USD 7.8 million · Dividend of USD 0.025 per share paid in the second quarter of 2018        · Höegh Esperanza commenced three-year FSRU/LNGC contract with CNOOC Subsequent events · Dividend of USD 0.025 per share declared in the third quarter of 2018 · Secured commitments for a USD 177 million debt financing for

Targovax ASA: Second quarter and first half year 2018 results

Oslo, Norway, 23 August 2018 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard to treat solid tumors, today announces its second quarter and first half year 2018 results. A meeting for investors, analysts and press will take place in Oslo today at 10:00 CET (details below).HIGHLIGHTS FOR THE SECOND QUARTER AND FIRST HALF YEAR 2018 · In January, Targovax announced that ONCOS-102 generated immune activation at both the systemic and lesional levels in checkpoint inhibitor (CPI) refractory melanoma in four out of the first

Nel ASA: Second quarter 2018 financial results

(Oslo, 23 August 2018) Nel ASA (“Nel”) reported revenues of NOK 135.8 million in the second quarter of 2018, up from NOK 39.1 million in the corresponding quarter last year, and an adjusted EBITDA of NOK -8.8 million. The company announced the construction of the world’s largest electrolyzer manufacturing plant, fully automated and able to deliver the most efficient electrolyzes at a game changing price. The total development will have a name plate capacity of 360 MW/year, approximately ten times the current annual production capacity, and the new facility will accommodate the multi-billion

Nuevolution AB (publ) announces its results for the second quarter of 2018

Stockholm, 22 August 2018. Nuevolution AB (publ) announces its report for the second quarter of 2018. The report is available on the company’s home page (www.nuevolution.com). The following is taken from the quarterly report. Financial summary April-June January-JuneSEK million 2018 2017 2018 2017Revenue from contracts with customers 0.6 5.9 8.8 7.4Total operating expenses, net -34.4 -34.7 -65.5 -66.0Operating result -33.9 -28.8 -56.

Nuevolution discloses the identity of its “Cytokine X” program being Interleukin IL-17A

and initiates promotion of its small molecule IL-17A inhibitor program targeting inflammatory diseasesStockholm, 22 August 2018. Today, Nuevolution AB (publ) announced the identity of its “Cytokine X” program being a lead discovery program targeting inhibition of Interleukin IL-17A using small molecules. Nuevolution’s small molecules may offer access to both topical (e.g. cream based) treatment as well as safe tablet-based treatment, whereas currently marketed IL-17A inhibitors are injectable and high-cost antibodies that come with potential adverse reactions from the treatment. The company

Contemplated sale of shares in Boozt AB (publ)

Press release, 22 August 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Carnegie Investment Bank AB (“Carnegie”) and Danske Bank A/S, Danmark, Sverige Filial (“Danske Bank”) have been retained by Sunstone Technology Ventures Fund II K/S (“Sunstone”), Ferd AS and a group of key employees (including CEO and CFO) (the “key employees”) (together the “Sellers”) to explore the opportunity to sell 2.3 to 3.0 million shares

Fiskars Corporation: Acquisition of Own Shares 22.08.2018

Fiskars Corporation NOTIFICATION   22.08.2018 at 18:30 EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 22.08.2018 Date 22.08.2018Exchange transaction BuyShare class FSKRSAmount 1500Average price/share 18.5833 EURHighest price/share 18.6200 EURLowest price/share 18.5200 EURTotal price 27,874.95 EUR The shares held by Fiskars Corporation on 22.08.2018: FSKRS  239,861 On behalf of Fiskars CorporationSkandinaviska Enskilda Banken AB (Publ)   Antti Salakka    Janne

Overwhelming impressions from all over Europe

The winners of the E1 | R1 Photo Award were honored during this year´s German Hiking Day which celebrated its 118th iterationThe two European long-distance routes E1 (hiking trail) and R1 (cycle path) together are more than 11,000 kilometers long, run through 16 countries and intersect near Detmold. Finding the most beautiful motifs along these paths of superlatives - that was the objective of the E1IR1 Photo Award. The competition which comprises a professional and an amateur contest was initiated by WALK, the Competence Center for Hiking at the foot of the Arminius Monument. The award

3rd Quarter Results

To view the PDF of this Earnings Release, please click on the link below.  http://www.rns-pdf.londonstockexchange.com/rns/6074Y_1-2018-8-22.pdf THIRD QUARTER 2018 EARNINGS RELEASE   ROYAL BANK OF CANADA REPORTS RECORD THIRD QUARTER 2018 RESULTS All amounts are in Canadian dollars and are based on financial statements prepared in compliance with International Accounting Standard 34 Interim Financial Reporting, unless otherwise noted. Effective November 1, 2017, we adopted IFRS 9 Financial Instruments. Prior period amounts are prepared in accordance with IAS 39 Financial

Allotment of Stock Options, ESOP 2017 program

The following primary insiders have been awarded employee stock options under the ESOP 2017 Program: Bente Brocks, Group Chief Accountant, has been awarded 500,000 options in Axactor SE Eilif Drageseth, Group Business Controller, has been awarded 100,000 options in Axactor SE For additional information, please contact:Johnny Tsolis, CFO, AxactorMobile phone: +47 913 35 461Email: johnny.tsolis@axactor.com About AxactorAxactor Group specializes in both Debt Collection and Debt Purchasing across several countries, with operations in Italy, Germany, Norway, Sweden and Spain.

Report from the Annual General Meeting of EQL Pharma AB (publ) on August 22nd, 2018

At EQL Pharma's Annual General Meeting, which was held today in Lund, August 22nd, 2018, the following decisions were made:Adoption of the balance sheet and income statement, disposition regarding the Company’s resultsThe annual general meeting resolved to adopt the balance sheet and income statement and the consolidated balance sheet and income statement for the financial year 2017-01-01 – 2018-03-31. The annual general meeting also resolved that no dividends shall be paid for the financial year 2017/2018. Discharge from liability for the Board of Directors and the Managing Director

Investor Report

To view this report in PDF, please click on the following link:   http://www.rns-pdf.londonstockexchange.com/rns/6053Y_1-2018-8-22.pdf    RBC Covered Bond Programme Monthly  Investor Report Calculation Date:                                            7/31/2018 This report contains information  regarding assets pledged as security (theCover Pool) in respect of the   obligationsunder the Covered Bonds issued under RBC'sGlobal Covered Bond   Programme as of theindicated Calculation Date.  Thecomposition of   the Cover Pool will changeas Loans are added and

Orkla ASA: Trade subject to notification - treasury shares

Orkla ASA has on 22 August 2018 bought 211,000 Orkla shares through broker at an average price of NOK 71.3275 per share. Orkla's total holding of treasury shares after this transaction is 18,229,259 shares. Orkla ASAOslo, 22 August 2018Ref.:IR & Communications ManagerElise A. HeidenreichTel.: +47 951 41 147 This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

Citycon Group successfully places EUR 300 million Eurobond

CITYCON OYJ   Stock Exchange Release   22 August 2018 at 17:45 hrsNOT TO BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO OR TO ANY PERSON LOCATED IN OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (TOGETHER THE "UNITED STATES"), AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.Citycon Group has successfully placed a EUR 300 million Eurobond (the "Bond"). The issuer of the Bond is Citycon Treasury B.V. and the

Axactor and Reolux successfully close loan facility with Nomura for refinancing of REO portfolios

Oslo, 22 August 2018 Axactor and Reolux Holding S.à r.l ("Reolux") today announced the closure of the approximately EUR 96 million senior secured term loan facility with Nomura International plc ("Nomura") to refinance Reolux's existing Spanish Real Estate Owned (REO) investments, as previously reported. Nomura acted as Arranger for the facility. Endre Rangnes, CEO of Axactor, commented: "Closing of this transaction is an important milestone in establishing our funding structure and will enable significant future portfolio investments for Axactor. We are very pleased to announce the

There are no items matching the current filter
There are no more items matching the current filter
Back to top